Medial retropharyngeal nodal region sparing radiotherapy versus standard radiotherapy in patients with nasopharyngeal carcinoma: open label, non-inferiority, multicentre, randomised, phase 3 trial.
Yan-Ping MaoShun-Xin WangTian-Sheng GaoNing ZhangXiao-Yu LiangFang-Yun XieYuan ZhangGuan-Qun ZhouRui GuoWei-Jie LuoYong-Jie LiShao-Qiang LiangLi LinWen-Fei LiXu LiuCheng XuYu-Pei ChenJia-Wei LvShao-Hui HuangLi-Zhi LiuJi-Bin LiLing-Long TangLei ChenYing SunJun MaPublished in: BMJ (Clinical research ed.) (2023)
ClinicalTrials.gov NCT03346109.
Keyphrases
- open label
- clinical trial
- study protocol
- early stage
- locally advanced
- radiation therapy
- phase ii
- double blind
- radiation induced
- phase ii study
- phase iii
- neoadjuvant chemotherapy
- randomized controlled trial
- lymph node
- rectal cancer
- squamous cell carcinoma
- robot assisted
- cross sectional
- placebo controlled
- minimally invasive